Building Domain AI for IVP Teams That
Accelerates Deals, Strengthens Portfolios, and Delivers
Decision-Ready Intelligence
IVP Domain-Pillar Model
Map Investment Workflows into AI-Ready Decision Units
Structure investment workflows into clear domains, pillars, SME functions, and decision boundaries for scalable AI systems.
R&D (Research & Discovery)
Functional Areas
-
Target Identification & Validation -
Omics & Biomarker Research
-
Preclinical Strategy
-
Translational Sciences
SLM USE CASES
Target identification & ranking
Literature & hypothesis synthesis
Biomarker–disease association
Preclinical risk & failure prediction
Protocol authoring & optimization
Inclusion criteria analysis
Safety signal detection
CSR & clinical narrative generation
CMC strategy interpretation
Analytical method selection
Specification justification
Process change impact analysis
Batch record review
Deviation root cause analysis
Supply risk & capacity assessment
Tech transfer readiness
Regulatory submission drafting
Health authority response
Change classification & impact
Label consistency verification
CAPA effectiveness assessment
Inspection readiness & analysis
Risk register intelligence
Change control impact assessme
Launch readiness evaluation
Competitive landscape synthesis
Market opportunity sizing
Scenario based forecasting
Patent & IP interpretation
Investment case & ROI reasoning
Contract & clause interpretation
Enterprise knowledge copilot
Cross domain decision intelligence
RWE evidence synthesis
Model & assumption explanation
Data pipeline & lineage mapping
CD (Clinical Development)
Functional Areas
-
Clinical Development Strategy
-
Trial Design & Protocols
-
Clinical Operations
-
Clinical Safety
-
Data Management & Biostats
SLM USE CASES
Target identification & ranking
Literature & hypothesis synthesis
Biomarker–disease association
Preclinical risk & failure prediction
Protocol authoring & optimization
Inclusion criteria analysis
Safety signal detection
CSR & clinical narrative generation
CMC strategy interpretation
Analytical method selection
Specification justification
Process change impact analysis
Batch record review
Deviation root cause analysis
Supply risk & capacity assessment
Tech transfer readiness
Regulatory submission drafting
Health authority response
Change classification & impact
Label consistency verification
CAPA effectiveness assessment
Inspection readiness & analysis
Risk register intelligence
Change control impact assessme
Launch readiness evaluation
Competitive landscape synthesis
Market opportunity sizing
Scenario based forecasting
Patent & IP interpretation
Investment case & ROI reasoning
Contract & clause interpretation
Enterprise knowledge copilot
Cross domain decision intelligence
RWE evidence synthesis
Model & assumption explanation
Data pipeline & lineage mapping
CM (Chemistry & Manufacturing – CMC)
Functional Areas
-
Drug Substance & Drug Product
-
Analytical Development
-
Process Development
-
Stability & Specifications
-
Control Strategy
SLM USE CASES
Target identification & ranking
Literature & hypothesis synthesis
Biomarker–disease association
Preclinical risk & failure prediction
Protocol authoring & optimization
Inclusion criteria analysis
Safety signal detection
CSR & clinical narrative generation
CMC strategy interpretation
Analytical method selection
Specification justification
Process change impact analysis
Batch record review
Deviation root cause analysis
Supply risk & capacity assessment
Tech transfer readiness
Regulatory submission drafting
Health authority response
Change classification & impact
Label consistency verification
CAPA effectiveness assessment
Inspection readiness & analysis
Risk register intelligence
Change control impact assessme
Launch readiness evaluation
Competitive landscape synthesis
Market opportunity sizing
Scenario based forecasting
Patent & IP interpretation
Investment case & ROI reasoning
Contract & clause interpretation
Enterprise knowledge copilot
Cross domain decision intelligence
RWE evidence synthesis
Model & assumption explanation
Data pipeline & lineage mapping
MSC (Manufacturing & Supply Chain)
Functional Areas
-
GMP Manufacturing
-
Packaging & Labeling
-
Supply Planning
-
Tech Transfer
-
Digital Manufacturing
SLM USE CASES
Target identification & ranking
Literature & hypothesis synthesis
Biomarker–disease association
Preclinical risk & failure prediction
Protocol authoring & optimization
Inclusion criteria analysis
Safety signal detection
CSR & clinical narrative generation
CMC strategy interpretation
Analytical method selection
Specification justification
Process change impact analysis
Batch record review
Deviation root cause analysis
Supply risk & capacity assessment
Tech transfer readiness
Regulatory submission drafting
Health authority response
Change classification & impact
Label consistency verification
CAPA effectiveness assessment
Inspection readiness & analysis
Risk register intelligence
Change control impact assessme
Launch readiness evaluation
Competitive landscape synthesis
Market opportunity sizing
Scenario based forecasting
Patent & IP interpretation
Investment case & ROI reasoning
Contract & clause interpretation
Enterprise knowledge copilot
Cross domain decision intelligence
RWE evidence synthesis
Model & assumption explanation
Data pipeline & lineage mapping
RA (Regulatory Affairs)
Functional Areas
-
Global Regulatory Strategy
-
Submissions & Lifecycle
-
Labeling
-
Health Authority Interactions
-
Post Approval Changes
SLM USE CASES
Target identification & ranking
Literature & hypothesis synthesis
Biomarker–disease association
Preclinical risk & failure prediction
Protocol authoring & optimization
Inclusion criteria analysis
Safety signal detection
CSR & clinical narrative generation
CMC strategy interpretation
Analytical method selection
Specification justification
Process change impact analysis
Batch record review
Deviation root cause analysis
Supply risk & capacity assessment
Tech transfer readiness
Regulatory submission drafting
Health authority response
Change classification & impact
Label consistency verification
CAPA effectiveness assessment
Inspection readiness & analysis
Risk register intelligence
Change control impact assessme
Launch readiness evaluation
Competitive landscape synthesis
Market opportunity sizing
Scenario based forecasting
Patent & IP interpretation
Investment case & ROI reasoning
Contract & clause interpretation
Enterprise knowledge copilot
Cross domain decision intelligence
RWE evidence synthesis
Model & assumption explanation
Data pipeline & lineage mapping
QRM (Quality & Risk Management)
Functional Areas
-
Quality Systems (QMS)
-
CAPA
-
Audits & Inspections
-
Risk Management
-
Change Control
SLM USE CASES
Target identification & ranking
Literature & hypothesis synthesis
Biomarker–disease association
Preclinical risk & failure prediction
Protocol authoring & optimization
Inclusion criteria analysis
Safety signal detection
CSR & clinical narrative generation
CMC strategy interpretation
Analytical method selection
Specification justification
Process change impact analysis
Batch record review
Deviation root cause analysis
Supply risk & capacity assessment
Tech transfer readiness
Regulatory submission drafting
Health authority response
Change classification & impact
Label consistency verification
CAPA effectiveness assessment
Inspection readiness & analysis
Risk register intelligence
Change control impact assessme
Launch readiness evaluation
Competitive landscape synthesis
Market opportunity sizing
Scenario based forecasting
Patent & IP interpretation
Investment case & ROI reasoning
Contract & clause interpretation
Enterprise knowledge copilot
Cross domain decision intelligence
RWE evidence synthesis
Model & assumption explanation
Data pipeline & lineage mapping
CMS (Commercial & Market Strategy)
Functional Areas
-
Portfolio & Launch Strategy
-
Market Research
-
Competitive Intelligence
-
Forecasting & Pricing
-
Lifecycle Management
SLM USE CASES
Target identification & ranking
Literature & hypothesis synthesis
Biomarker–disease association
Preclinical risk & failure prediction
Protocol authoring & optimization
Inclusion criteria analysis
Safety signal detection
CSR & clinical narrative generation
CMC strategy interpretation
Analytical method selection
Specification justification
Process change impact analysis
Batch record review
Deviation root cause analysis
Supply risk & capacity assessment
Tech transfer readiness
Regulatory submission drafting
Health authority response
Change classification & impact
Label consistency verification
CAPA effectiveness assessment
Inspection readiness & analysis
Risk register intelligence
Change control impact assessme
Launch readiness evaluation
Competitive landscape synthesis
Market opportunity sizing
Scenario based forecasting
Patent & IP interpretation
Investment case & ROI reasoning
Contract & clause interpretation
Enterprise knowledge copilot
Cross domain decision intelligence
RWE evidence synthesis
Model & assumption explanation
Data pipeline & lineage mapping
CLS (Corporate, Legal & Strategy)
Functional Areas
-
Corporate Strategy
-
Legal & IP
-
Finance
-
HR / IT
-
PMO
SLM USE CASES
Target identification & ranking
Literature & hypothesis synthesis
Biomarker–disease association
Preclinical risk & failure prediction
Protocol authoring & optimization
Inclusion criteria analysis
Safety signal detection
CSR & clinical narrative generation
CMC strategy interpretation
Analytical method selection
Specification justification
Process change impact analysis
Batch record review
Deviation root cause analysis
Supply risk & capacity assessment
Tech transfer readiness
Regulatory submission drafting
Health authority response
Change classification & impact
Label consistency verification
CAPA effectiveness assessment
Inspection readiness & analysis
Risk register intelligence
Change control impact assessme
Launch readiness evaluation
Competitive landscape synthesis
Market opportunity sizing
Scenario based forecasting
Patent & IP interpretation
Investment case & ROI reasoning
Contract & clause interpretation
Enterprise knowledge copilot
Cross domain decision intelligence
RWE evidence synthesis
Model & assumption explanation
Data pipeline & lineage mapping
DADS (Data, Analytics & Decision Sciences)
Functional Areas
-
Data Engineering
-
Advanced Analytics
-
AI / ML
-
Real World Evidence
-
Decision Intelligence
SLM USE CASES
Target identification & ranking
Literature & hypothesis synthesis
Biomarker–disease association
Preclinical risk & failure prediction
Protocol authoring & optimization
Inclusion criteria analysis
Safety signal detection
CSR & clinical narrative generation
CMC strategy interpretation
Analytical method selection
Specification justification
Process change impact analysis
Batch record review
Deviation root cause analysis
Supply risk & capacity assessment
Tech transfer readiness
Regulatory submission drafting
Health authority response
Change classification & impact
Label consistency verification
CAPA effectiveness assessment
Inspection readiness & analysis
Risk register intelligence
Change control impact assessme
Launch readiness evaluation
Competitive landscape synthesis
Market opportunity sizing
Scenario based forecasting
Patent & IP interpretation
Investment case & ROI reasoning
Contract & clause interpretation
Enterprise knowledge copilot
Cross domain decision intelligence
RWE evidence synthesis
Model & assumption explanation
Data pipeline & lineage mapping
IVP Value Areas
Where Investment AI Creates Decision Advantage
Convert deal data, diligence documents, market signals, and portfolio updates into governed intelligence for faster and better investment decisions.
01
Deal Intelligence
Screen opportunities, compare deal signals, summarize company profiles, and prioritize targets for deeper evaluation.
02
Diligence Acceleration
Review financials, decks, contracts, market data, and diligence notes to surface risks, gaps, and key questions faster.
03
Investment Memo Support
Transform fragmented research into structured thesis, valuation logic, risk notes, and committee-ready investment memos.
04
Portfolio Monitoring
Track KPIs, milestones, operating risks, follow-on needs, and value-creation priorities across portfolio companies.
05
Risk & Scenario Reasoning
Model downside cases, sensitivity shifts, market exposure, competitive risk, and strategic decision alternatives.
06
LP & Reporting Intelligence
Generate investor updates, fund summaries, performance narratives, and evidence-backed reporting with traceable context.
Why Choose TekFrameworks?
Built for High-Stakes Investment Decisions
TekFrameworks brings domain structure, governed reasoning, and decision-ready AI systems to investment, venture, and portfolio workflows.
Decision-First Architecture
Structure IVP workflows around real investment decisions, from sourcing and diligence to portfolio monitoring and exits.
Analyst-Aligned Workflows
Reduce manual review by aligning AI with analyst workflows, investment committee needs, fund operations, and reporting cycles.
Evidence-Backed Outputs
Move beyond summaries into traceable investment memos, diligence findings, portfolio insights, and LP-ready narratives.
Governance Built In
Embed auditability, access control, compliance checkpoints, decision ownership, and review trails into investment AI workflows.
Scalable Intelligence Layer
Build reusable AI patterns across funds, strategies, sectors, and portfolio companies using SparLM, FoRMLM, and Brain Units.
Testimonials
Investment Teams Turning Signals into Decisions
Trusted by venture, investment, and portfolio teams to structure deal research, diligence, risk, reporting, and portfolio workflows into governed AI-ready decisions.
TekFrameworks helped us move from scattered deal notes and research files into a more structured AI-ready diligence workflow.
Their domain-pillar approach made it easier to map sourcing, diligence, investment evaluation, and portfolio monitoring into practical AI use cases.
What stood out was the focus on evidence-backed decision support. The roadmap helped us think beyond summaries toward traceable investment intelligence.
TekFrameworks helped us structure AI opportunities across deal screening, market intelligence, risk scenarios, LP reporting, and exit planning.
FAQ’S
Questions on IVP AI? We’ve Got You Covered.
Clear answers on how TekFrameworks structures investment, venture, and portfolio workflows into governed AI-ready decision systems.
The IVP model structures investment, venture, and portfolio management workflows into domains, pillars, SME functions, and decision units.
It covers deal sourcing, due diligence, investment evaluation, portfolio management, fund operations, investor relations, risk modeling, exits, and market intelligence.
It helps teams analyze decks, reports, financials, diligence notes, market research, and portfolio updates to surface risks, gaps, and decision signals.
Yes. TekFrameworks can structure outputs such as investment memos, risk notes, thesis summaries, evidence trails, and committee-ready decision packs.
Governance can be embedded through access control, evidence traceability, review checkpoints, audit logs, and decision ownership across workflows.
It is suitable for VC firms, PE funds, family offices, portfolio teams, fund operators, investment analysts, and corporate strategy teams.
US Office address
50 Division Street, Suite 501,
Somerville, NJ 08876 , US
- Image
- SKU
- Rating
- Price
- Stock
- Availability
- Add to cart
- Description
- Content
- Weight
- Dimensions
- Additional information